Selected Publications (2019 – Present)

Peer-reviewed journal articles

  1. Khanal S, Turnbull PR, Kim L, Phillips JR. Response of the human choroid to short-term changes in eyelid and periocular temperature. Clin Exp Optom. 2024 Jul 16:1-7.
  2. Davies LN, Biswas S, Bullimore M, Cruickshank F, Estevez JJ, Khanal S, Kollbaum P, Marcotte-Collard R, Montani G, Plainis S, Richdale K, Simard P, Wolffsohn JS. BCLA CLEAR presbyopia: Mechanism and optics. Cont Lens Anterior Eye. 2024 May 24:102185.
  3. Khanal S, Phillips JR. Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful? JAMA Ophthalmol. Published online February 15, 2024. doi:10.1001/jamaophthalmol.2023.6771.
  4. Salzano AD, Khanal S, Cheung NL, Weise KK, Jenewein EC, Horn DM, Mutti DO, Gawne TJ. Repeated Low-level Red-light Therapy: The Next Wave in Myopia Management? Optom Vis Sci. 2023 Dec 1;100(12):812-822.
  5. Khanal S. Is myopia a disease or just a dis-ease? Ophthalmic Physiol Opt. 2023 Jul;43(4):595-597. doi: 10.1111/opo.13145. Epub 2023 Apr 17. PMID: 37069742.
  6. Khanal S, Norton TT, Gawne TJ. Limited bandwidth short-wavelength light produces slowly-developing myopia in tree shrews similar to human juvenile-onset myopia. Vision Research. 2023; 204: 108161.
  7. Dahal M, Dahal HN, Gautam P, Shrestha JB, Khanal S. Pattern visual evoked potential and foveal sensitivity in amblyopia. Doc Ophthalmol. 2023 Oct;147(2):109-119.
  8. Khanal S, Norton TT, Gawne TJ. Amber light treatment produces hyperopia in tree shrews. Ophthalmic Physiol Opt. 2021 Aug 11.
  9. Norton TT, Khanal S, Gawne TJ. Tree shrews do not maintain emmetropia in initially-focused narrow-band cyan light. Exp. Eye Res. 2021 Mar 10:108525.
  10. Logan NS, Radhakrishnan H, Cruickshank F, Allen PM, Bandella PK, Davies LN, Hasebe S, Khanal S, Schmid KL, Vera-Diaz FA, Wolffsohn JS. IMI: Accommodation and Binocular Vision in Myopia Development and Progression. Invest. Ophthalmol. Vis. Sci. 2021;62(5):4.
  11. Khanal S, Bai Y, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived cholesteryl and wax esters in meibomian gland dysfunction and tear film structure. The Ocular Surface. 2022; 23:12-23.
  12. Bai Y, Ngo W, Khanal S, Nichols JJ. Characterization of the Thickness of the Tear Film Lipid Layer in Meibomian Gland Dysfunction using High-Resolution Optical Microscopy. The Ocular Surface. 2022; 24: 34-39.
  13. Turnbull P, Khanal S, Dakin S. The effect of cellphone position on driving and gaze behavior. Scientific reports. 2021 Apr 8;11(1):1-0.
  14. Ramamoorthy P, Khanal S (co-first author), Nichols JJ. Inflammatory proteins associated with contact lens-related dry eye. Contact Lens and Anterior Eye. 2021 Apr 3:101442.
  15. Khanal S, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived (o-acyl)-omega-hydroxy fatty acids in meibomian gland dysfunction. The Ocular Surface. 2021; 21: 118-128.
  16. Khanal S, Bai Y, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived (o-acyl)-omega-hydroxy fatty acids as biomarkers of tear film dynamics in meibomian gland dysfunction and dry eye disease. Invest Ophthalmol Vis Sci. 2021;62(9):13
  17. Khanal S, Paudel N, Joshi MR. Optometry in Nepal: historical perspectives. Clinical and Experimental Optometry. 2021 May 2:1-4.
  18. Khanal S, Paudel N, Adhikary R, Joshi MR. Topical Review: Optometry in Nepal-Clinical Practice, Research Advances, and Challenges. Optom Vis Sci. 2023 Feb 1;100(2):134-142.
  19. Bai Y, Ngo W, Khanal S, Nichols KK, Nichols JJ. Human precorneal tear film and lipid layer dynamics in meibomian gland dysfunction. The Ocular Surface. 2021 Mar 23:S1542-0124(21)00018-5.
  20. Khanal S, Rathod SN, Phillips JR. The acute effect of atropine eye drops on the human full-field electroretinogram. Doc Ophthalmol. 2021 Jun;142(3):315-328. Epub 2020.
  21. Kharal A, Khanal S (co-first author), Shrestha JB, Shrestha GS, Paudel N. Flash VEP in clinically stable pre-term and full-term infants. 2020;141(3):259-267.
  22. Khanal S, Phillips JR. Which low-dose atropine for myopia control? Clinical and Experimental Optometry. 2019; 103: 230-232.
  23. Khanal S, Turnbull PRK, Lee N, Phillips JR. Effect of atropine on global flash mfERG responses to retinal defocus. Invest Ophthalmol Vis Sci. 2019;1(60):218-225.
  24. Khanal S, Turnbull PRK, Vaghefi E, Phillips JR. Repeatability of arterial spin labeling MRI in measuring blood perfusion in the human eye. JMRI. 2019 Apr;49(4):966-74.

Editor-reviewed articles

  1. Khanal S. Repeated low-level “laser” red light therapy for childhood myopia. Mastering Myopia, Contact Lens Spectrum. February 7, 2024.
  2. Khanal S. Combination treatment strategy for myopia control. Mastering Myopia, Contact Lens Spectrum. May 18, 2022.
  3. Khanal S. Not all myopias are the same. Mastering Myopia, Contact Lens Spectrum. April 20, 2022.
  4. Khanal S. Myopia—Not Just “Nearsightedness” But a Disease. Mastering Myopia, Contact Lens Spectrum. September 15, 2021.
  5. Khanal S. Myopia Management: A Specialty or Primary Care? Mastering Myopia, Contact Lens Spectrum. July 21, 2021.
  6. Khanal S. Ocular Growth Charts: A New Decision-Making Tool For Myopia Management. Mastering Myopia, Contact Lens Spectrum. June 23, 2021.
  7. Khanal S. Evidence-based Myopia Management: Clinical Considerations. MiVision. December 2020. (Continuing Professional Development Article)
  8. Khanal S. 0.01% Atropine’s puzzling disconnect. MiVision. February 2020.
  9. Khanal S. Which low-dose atropine for myopia control? NZOptics. March 2020.
  10. Khanal S. Optometry from New Zealand to Nepal. NZAO TVC. February 2020.